Clinical results with recombinant human interleukin-3.
Ganser
A
A
Abteilung für Hämatologie, Johann Wolfgang Goethe Universität, Frankfurt, West Germany.
D000741:Anemia, Aplastic / Q000097:blood / Q000628:therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001853:Bone Marrow / Q000187:drug effects* / Q000473:pathology; D017321:Clinical Trials, Phase I as Topic; D004334:Drug Administration Schedule; D006412:Hematopoietic Stem Cells / Q000187:drug effects; D006801:Humans; D007377:Interleukin-3 / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000628:therapy*; D009369:Neoplasms / Q000097:blood / Q000628:therapy
D000970:Antineoplastic Agents; D007377:Interleukin-3